IBC-Oxford University2023_BJSPoster_13Short-term outcomes of sleeve gastrectomy for morbid obesity: A single-center experience

Abstract

Abstract Background Sleeve gastrectomy is a commonly performed procedure for individuals with morbid obesity. Short-term outcomes of sleeve gastrectomy are often assessed in terms of excess body mass index loss (EBMIL). These measures provide an indication of the amount of weight lost relative to the excess weight or excess body mass index prior to surgery. Methods In this study, we evaluated the short-term outcomes of sleeve gastrectomy in patients with morbid obesity. A retrospective analysis was conducted on a series of Laparoscopic Sleeve Gastrectomy (LSG) procedures performed between January 2020 and December 2022. The medical records of all patients who underwent LSG were reviewed and enrolled. Results The study included 162 patients with morbid obesity (mean age: 38 years; 72% female; mean preoperative body mass index: 41 kg/m²). At 6 months postoperatively, the percentage of excess body mass index loss was 69% with a follow-up rate of 81%. At 1 year, it was 83% with a follow-up rate of 72%, and at 2 years, it was 79% with a follow-up rate of 44%. These findings indicate that sleeve gastrectomy leads to substantial weight loss in the short term, as measured by EBMIL. Conclusion Sleeve gastrectomy demonstrates favorable short-term outcomes in terms of excess body mass index loss (EBMIL) for individuals with morbid obesity. These measures provide evidence of significant weight reduction following the procedure, highlighting the effectiveness of sleeve gastrectomy as a treatment option for morbid obesity.